Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1979-12-10
1984-10-30
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
424177, A61K 3900, A61K 3704, A61K 39395
Patent
active
044799349
ABSTRACT:
What is disclosed is a method for the therapy of immunocomplex diseases with an agent which contains Fc-reagents that react with the Fc-part of the antibody contained in the immunocomplex, but which themselves do not posses an immunologically active Fc-part or an Fc-part capable of being activated.
REFERENCES:
Chemical Abstracts, vol. 82, p. 361, Abst. No. 84193u, "Interaction of Antibodies, Complement Components and Various Cell Types in Immunity Against Viruses and Pyogeneic Bacteria", 1975.
Chemical Abstracts, vol. 79, p. 318, Abst. No. 30333j, Eden et al., "Mechanism of Binding Soluble Immune Complexes to Lymphocytes", 1973.
Chemical Abstracts, vol. 79, p. 318, Abst. No. 30334k, Yoshino et al., "Neutralization of Herpes Simplex Virus, VI, Mode of Action of Complement Upon Antibody-Sensitized Virus", 1973.
Chemical Abstracts, vol. 84, p. 260, Abst. No. 56290w, Masson et al., "Analysis of Biological Fluids", 1976.
Chemical Abstracts, vol. 84, p. 260, Abst. No. 56291x, Masson et al., "Analysis of Biological Fluids", 1976.
Nisonoff et al., Arch. Biochem. Biophys., vol. 89, p. 230, (1960).
Sedlacek et al., Behring Institute Mitteilungen, vol. 64, p. 78, (1979).
Sedlacek, Klin. Wochenschr., vol. 58, pp. 543, 593, (1980).
Haakenstad et al., Biology of Immune Complexes in "Autoimmunity", Ed. by Talal, Academic Press, (1977), pp. 278-350.
Porter, Biochem. J., vol. 73, p. 119, (1959).
Haupt et al., Klinische Wochenschryt, vol. 47, p. 270, (1969).
Nisonoff et al., Arch. Biochem. Biophys., vol. 89, p. 230, (1960).
Sedlacek Hans-Harald
Seiler Friedrich R.
Behringwerke Aktiengesellschaft
Hazel Blondel
LandOfFree
Method and agent for the therapy of immunocomplex diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and agent for the therapy of immunocomplex diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and agent for the therapy of immunocomplex diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1101784